<?xml version="1.0" encoding="UTF-8"?>
<crossref_result xmlns="http://www.crossref.org/qrschema/3.0" version="3.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/qrschema/3.0 http://www.crossref.org/schemas/crossref_query_output3.0.xsd">
  <query_result>
    <head>
      <doi_batch_id>none</doi_batch_id>
    </head>
    <body>
      <query status="resolved">
        <doi type="journal_article">10.31254/dentistry.2020.5306</doi>
        <crm-item name="publisher-name" type="string">Ovid Technologies (Wolters Kluwer Health)</crm-item>
        <crm-item name="prefix-name" type="string">Ovid Technologies (Wolters Kluwer) - Medknow Publications</crm-item>
        <crm-item name="member-id" type="number">276</crm-item>
        <crm-item name="citation-id" type="number">130548930</crm-item>
        <crm-item name="journal-id" type="number">303226</crm-item>
        <crm-item name="deposit-timestamp" type="number">20210928114411454</crm-item>
        <crm-item name="owner-prefix" type="string">10.4103</crm-item>
        <crm-item name="last-update" type="date">2025-06-20T07:13:34Z</crm-item>
        <crm-item name="created" type="date">2021-09-28T12:18:59Z</crm-item>
        <crm-item name="citedby-count" type="number">0</crm-item>
        <doi_record>
          <crossref xmlns="http://www.crossref.org/xschema/1.1" xsi:schemaLocation="http://www.crossref.org/xschema/1.1 http://doi.crossref.org/schemas/unixref1.1.xsd">
            <journal>
              <journal_metadata>
                <full_title>The Journal of Medical Research</full_title>
                <abbrev_title>J. Med. Res.</abbrev_title>
                <issn media_type="electronic">23957565</issn>
                <doi_data>
                  <doi>10.31254/jmr</doi>
                  <resource>http://www.medicinearticle.com/</resource>
                </doi_data>
              </journal_metadata>
              <journal_issue>
                <publication_date media_type="online">
                  <month>1</month>
                  <day>31</day>
                  <year>2021</year>
                </publication_date>
                <journal_volume>
                  <volume>5</volume>
                </journal_volume>
                <issue>3</issue>
              </journal_issue>
              <journal_article publication_type="full_text">
                <titles>
                  <title>Application tissue engineering in the treatment of Temporomandibular disorders</title>
                </titles>
                <contributors>
                  <organization sequence="first" contributor_role="author">Graduate Student, Department of Oromaxillofacial Surgery, Kerman, Iran</organization>
                  <person_name sequence="first" contributor_role="author">
                    <given_name>Yeganeh</given_name>
                    <surname>Arian</surname>
                  </person_name>
                </contributors>
                <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xml:lang="en">
                  <jats:p>Aim: The aim of this study was to examine the articles of the new use of engineered tissues in the treatment problems of joint temporomandibular jaw. Materials and methods: In order to carry out this study, a review of all articles source, books, Medline (PubMed) and Google scholar with a focus on the issue of the use of engineered tissues in the temporomandibular disorders in the period of time 1990 to 2018 done. Results: Using the approach of engineered tissue for the different treatment of defects of temporomandibular joint disorders can be helpful is that to them out of there. Ability to build cartilage similar to cartilage naturally by way of a new provision has been. Also, to help gene therapy, cell therapy, reconstruction defect of osteocondral, Ramus even part of the condyle of the left with the ability to comply with part of the left and doing function properly with the remaining part of the use of cells from stem mesenchymal (MSCs). There are factors of growth and cytokine are and provide a scaffold made of polymeric bio- compatible and industries can be differentiated cells from stem mesenchymal to cells of chondrocytes and osteoblasts to cause it. Although they are tried on this is that more regeneration of muscle - Skeletal with the use of the technology and rehabilitation of cells to patients without using scaffolds. Conclusion: As a result of this study, the review showed that gives the engineered tissue can be replaced by the old treatment of Temporomandibular joint (TMJ) and reconstructed it be, that benefits such as reducing damage to places of and reduce the risk of rejection of links.</jats:p>
                </jats:abstract>
                <publication_date media_type="online">
                  <month>1</month>
                  <day>31</day>
                  <year>2021</year>
                </publication_date>
                <pages>
                  <first_page>137</first_page>
                  <last_page>140</last_page>
                </pages>
                <doi_data>
                  <doi>10.31254/dentistry.2020.5306</doi>
                  <resource>http://www.dentistryscience.com/IJDR_202053_06.pdf</resource>
                </doi_data>
              </journal_article>
            </journal>
          </crossref>
        </doi_record>
      </query>
    </body>
  </query_result>
</crossref_result>